Middle East & Africa Viral Vector Purification Market to 2032
Overview
The Middle East & Africa Viral Vector Purification Market is expected to reach a 35.41 USD Million by 2032 and is projected to grow at a CAGR of 20.20% from 2025 to 2032.
Middle East & Africa Viral Vector Purification Market 2018-2032 USD Million
Middle East & Africa Viral Vector Purification Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 13.72 USD Million
- Projected Market Size (2032): 35.41 USD Million
- CAGR (2025-2032): 20.20%
Key Findings of Middle East & Africa Viral Vector Purification Market
- The Middle East & Africa Viral Vector Purification Market was valued at 13.72 USD Million in 2024.
- The Middle East & Africa Viral Vector Purification Market is likely to grow at a CAGR of 20.20% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Upstream Processing in Workflow Segment accounted for the largest share of the market with a revenue of 12.23 USD Million
- The fastest growing segment Chromatography in Purification Technique Segment grew Fastest with a CAGR of 23.26% during the forecast period from 2024 to 2032.
Middle East & Africa Viral Vector Purification Market Scope
- Other
- Cancer
- Veterinary Disease
- Infectious Diseases
- Genetic Disorders
- Antisense & RNAI
- Vaccinology
- Cell Therapy
- Gene Therapy
- Contract Research Organizations
- Biotechnology Companies
- Contract Development And Manufacturing Organization (CDMO)
- Pharmaceutical Companies
- Academic/ Research Institutes
- Vaccine Virus
- Retroviral Vectors
- Other
- Lentivirus
- Adenoviral Vectors
- Adeno-Associated Viral Vectors
- Downstream Processing
- Upstream Processing
- Commercial
- Preclinical / Clinical
- Ex Vivo
- In Vivo
- Services
- Products
- Two-Phase Extraction Systems
- Precipitation
- Ultrafiltration
- Density-Gradient Ultracentrifugation
- Chromatography
Middle East & Africa Viral Vector Purification Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 13.72 USD Million |
| Market Value in 2032 | 35.41 USD Million |
| CAGR (2025-2032) | 20.20% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Disease Indication,Application,End User,By Type,Workflow,Scale of Operation,Delivery Mode,Product & Services,Purification Technique |
Regional Insights:
-
Leading Market (2024-2032): Middle East & Africa, leading in terms of revenue 13.72 USD Million in 2024
- Key Country: South Africa, leading in terms of revenue with value of 4.82 USD Million in 2024.
Segments and Scope
-
Middle East & Africa Viral Vector Purification Market to 2032, By Disease Indication
- Genetic Disorders is the largest segment in Middle East & Africa Viral Vector Purification Market to 2032 with a revenue of 7.41 USD Million in the year 2024.
- Infectious Diseases is the Fastest growing segment in Middle East & Africa Viral Vector Purification Market to 2032 with a Growth rate of 20.84 % in forecast period 2025-2032.
-
Middle East & Africa Viral Vector Purification Market to 2032, By Application
- Gene Therapy is the largest segment in Middle East & Africa Viral Vector Purification Market to 2032 with a revenue of 7.22 USD Million in the year 2024.
- Gene Therapy is the Fastest growing segment in Middle East & Africa Viral Vector Purification Market to 2032 with a Growth rate of 22.45 % in forecast period 2025-2032.
-
Middle East & Africa Viral Vector Purification Market to 2032, By End User
- Academic/ Research Institutes is the largest segment in Middle East & Africa Viral Vector Purification Market to 2032 with a revenue of 6.36 USD Million in the year 2024.
- Academic/ Research Institutes is the Fastest growing segment in Middle East & Africa Viral Vector Purification Market to 2032 with a Growth rate of 21.27 % in forecast period 2025-2032.
-
Middle East & Africa Viral Vector Purification Market to 2032, By By Type
- Adeno-Associated Viral Vectors is the largest segment in Middle East & Africa Viral Vector Purification Market to 2032 with a revenue of 7.10 USD Million in the year 2024.
- Lentivirus is the Fastest growing segment in Middle East & Africa Viral Vector Purification Market to 2032 with a Growth rate of 20.59 % in forecast period 2025-2032.
-
Middle East & Africa Viral Vector Purification Market to 2032, By Workflow
- Upstream Processing is the largest segment in Middle East & Africa Viral Vector Purification Market to 2032 with a revenue of 12.23 USD Million in the year 2024.
- Upstream Processing is the Fastest growing segment in Middle East & Africa Viral Vector Purification Market to 2032 with a Growth rate of 20.51 % in forecast period 2025-2032.
-
Middle East & Africa Viral Vector Purification Market to 2032, By Scale of Operation
- Preclinical / Clinical is the largest segment in Middle East & Africa Viral Vector Purification Market to 2032 with a revenue of 8.43 USD Million in the year 2024.
- Preclinical / Clinical is the Fastest growing segment in Middle East & Africa Viral Vector Purification Market to 2032 with a Growth rate of 21.80 % in forecast period 2025-2032.
-
Middle East & Africa Viral Vector Purification Market to 2032, By Delivery Mode
- In Vivo is the largest segment in Middle East & Africa Viral Vector Purification Market to 2032 with a revenue of 9.07 USD Million in the year 2024.
- In Vivo is the Fastest growing segment in Middle East & Africa Viral Vector Purification Market to 2032 with a Growth rate of 21.50 % in forecast period 2025-2032.
-
Middle East & Africa Viral Vector Purification Market to 2032, By Product & Services
- Products is the largest segment in Middle East & Africa Viral Vector Purification Market to 2032 with a revenue of 10.60 USD Million in the year 2024.
- Products is the Fastest growing segment in Middle East & Africa Viral Vector Purification Market to 2032 with a Growth rate of 21.07 % in forecast period 2025-2032.
-
Middle East & Africa Viral Vector Purification Market to 2032, By Purification Technique
- Chromatography is the largest segment in Middle East & Africa Viral Vector Purification Market to 2032 with a revenue of 6.51 USD Million in the year 2024.
- Chromatography is the Fastest growing segment in Middle East & Africa Viral Vector Purification Market to 2032 with a Growth rate of 23.26 % in forecast period 2025-2032.
Middle East & Africa Viral Vector Purification Market Company Share Analysis
| Company Name |
|
||
| Merck KGaA | |||
| Thermo Fisher Scientific Inc. | |||
| Agilent Technologies, Inc. | |||
| FUJIFILM Diosynth Biotechnologies | |||
| Cytiva | |||
Middle East & Africa Viral Vector Purification Market Geographical Sales Distribution, 2018-2032 USD Million
Middle East & Africa Viral Vector Purification Market Company Profiling
Industry Related Reports
Frequently Asked Questions
Middle East & Africa Viral Vector Purification Market Scope
- Other
- Cancer
- Veterinary Disease
- Infectious Diseases
- Genetic Disorders
- Antisense & RNAI
- Vaccinology
- Cell Therapy
- Gene Therapy
- Contract Research Organizations
- Biotechnology Companies
- Contract Development And Manufacturing Organization (CDMO)
- Pharmaceutical Companies
- Academic/ Research Institutes
- Vaccine Virus
- Retroviral Vectors
- Other
- Lentivirus
- Adenoviral Vectors
- Adeno-Associated Viral Vectors
- Downstream Processing
- Upstream Processing
- Commercial
- Preclinical / Clinical
- Ex Vivo
- In Vivo
- Services
- Products
- Two-Phase Extraction Systems
- Precipitation
- Ultrafiltration
- Density-Gradient Ultracentrifugation
- Chromatography
Frequently Asked Questions
Middle East & Africa Viral Vector Purification Market Company Profiling
Frequently Asked Questions
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.